TELO   $4.54  11.55% Market Closed After Close 4.44 -2.20%

Telomir Pharmaceuticals Inc
Total Cash 1.88M
totalCashPerShare 0.064
EBITDA
Total Debt 140.34K
quickRatio 3.77
currentRatio 3.935
Total Revenue
debtToEquity 8.953
Revenue/Share
ROA -0.84488
ROE -6.86907
grossProfits
freeCashflow -2.51M
operatingCashflow -6.55M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 124.10M
forwardPE
floatShares 17.47M
sharesOutstanding 29.61M
sharesShort 576.96K
sharesShortPriorMonth 131.60K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.43%
heldPercentInstitutions 0.01%
Short Ratio help_outline 2.94%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 0.053
Price To Book help_outline 80.19
earningsQuarterlyGrowth
netIncomeToCommon -18.74M
trailingEps -0.63%
forwardEps
enterpriseToEbitda
lastDividendValue
lastDividendDate
currentQuarterEstimate
institutionsCount 41
lastUpdated Nov. 2, 2024, 7:08 a.m.